Bairey O, Taliansky A, Glik A, Amiel A, et al. A phase 2 study of ibrutinib maintenance following first-line high-dose methotrexate-based chemotherapy for elderly patients with primary central nervous system lymphoma. Cancer 2023 Aug 12. doi: 10.1002/cncr.34985.
PMID: 37572086